128 related articles for article (PubMed ID: 10228798)
1. E-cadherin expression correlates with tumor differentiation in colorectal cancer.
Karatzas G; Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Riza F; Papanikolaou D
Hepatogastroenterology; 1999; 46(25):232-5. PubMed ID: 10228798
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression as a differentiation marker in gastric cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study.
Dorudi S; Sheffield JP; Poulsom R; Northover JM; Hart IR
Am J Pathol; 1993 Apr; 142(4):981-6. PubMed ID: 7682766
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer.
Kwak JM; Min BW; Lee JH; Choi JS; Lee SI; Park SS; Kim J; Um JW; Kim SH; Moon HY
Dis Colon Rectum; 2007 Nov; 50(11):1873-80. PubMed ID: 17828401
[TBL] [Abstract][Full Text] [Related]
5. Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis.
Saito T; Masuda N; Miyazaki T; Kanoh K; Suzuki H; Shimura T; Asao T; Kuwano H
Oncol Rep; 2004 Mar; 11(3):605-11. PubMed ID: 14767510
[TBL] [Abstract][Full Text] [Related]
6. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Alexiou D; Kalahanis N; Rosenberg T; Bastounis E
Anticancer Res; 1998; 18(6A):4177-80. PubMed ID: 9891464
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
[TBL] [Abstract][Full Text] [Related]
8. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
10. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB
Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
12. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer.
Shun CT; Wu MS; Lin JT; Wang HP; Houng RL; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1998; 45(22):944-9. PubMed ID: 9755986
[TBL] [Abstract][Full Text] [Related]
14. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
[TBL] [Abstract][Full Text] [Related]
15. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.
Pignatelli M; Ansari TW; Gunter P; Liu D; Hirano S; Takeichi M; Klöppel G; Lemoine NR
J Pathol; 1994 Dec; 174(4):243-8. PubMed ID: 7884585
[TBL] [Abstract][Full Text] [Related]
16. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration.
Mayer B; Johnson JP; Leitl F; Jauch KW; Heiss MM; Schildberg FW; Birchmeier W; Funke I
Cancer Res; 1993 Apr; 53(7):1690-5. PubMed ID: 8453643
[TBL] [Abstract][Full Text] [Related]
18. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
Ngan CY; Yamamoto H; Seshimo I; Ezumi K; Terayama M; Hemmi H; Takemasa I; Ikeda M; Sekimoto M; Monden M
J Surg Oncol; 2007 Jun; 95(8):652-62. PubMed ID: 17443723
[TBL] [Abstract][Full Text] [Related]
19. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
[TBL] [Abstract][Full Text] [Related]
20. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]